pmid	doi	year	title	Hugo_Symbol
33870156	10.1016/j.jhepr.2021.100250	2022	Genetic or pharmacological reduction of cholangiocyte senescence improves inflammation and fibrosis in the <i>Mdr2</i> <sup><i>-/-</i></sup>  mouse.	CASP8
34276918	10.4084/MJHID.2021.049	2022	Crocin Promotes Apoptosis in Human EBV-Transformed B-Lymphocyte via Intrinsic Pathway.	CASP8
34302634	10.1007/s13258-021-01142-8	2022	Lactucin induces apoptosis through reactive oxygen species-mediated BCL-2 and CFLAR<sub>L</sub> downregulation in Caki-1 cells.	CASP8
34853447	10.1038/s41418-021-00908-7	2022	Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1.	CASP8
35178927	10.19540/j.cnki.cjcmm.20210902.701	2022	[Molecular mechanism of Ganoderma against gastric cancer based on network pharmacology and experimental test].	CASP8
35628538	10.3390/ijms23105721	2022	Therapeutic Potential of Pretreatment with Exosomes Derived from Stem Cells from the Apical Papilla against Cisplatin-Induced Acute Kidney Injury.	CASP8
31954371	10.1016/j.redox.2019.101403	2021	Superoxide induced inhibition of death receptor signaling is mediated via induced expression of apoptosis inhibitory protein cFLIP.	CASP8
32575162	10.1002/cbf.3569	2021	Characterization of antiapoptotic microRNAs in primary Sjögren's syndrome.	CASP8
33039058	10.1016/S1875-5364(20)60019-X	2021	Dracocephalum palmatum Stephan extract induces apoptosis in human prostate cancer cells via the caspase-8-mediated extrinsic pathway.	CASP8
33162537	10.11406/rinketsu.61.1365	2021	[Lymphoproliferative disorders and inborn errors of immunity].	CASP8
33241658	10.1111/jcmm.16117	2021	Anti-coronavirus disease 2019 (COVID-19) targets and mechanisms of puerarin.	CASP8
33297339	10.3390/nu12123755	2021	Gene Expression Alterations Associated with Oleuropein-Induced Antiproliferative Effects and S-Phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells.	CASP8
33356695	10.1080/10408363.2020.1855623	2021	Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS).	CASP8
33913583	10.1002/cbin.11619	2021	Nuclear respiratory factor 1 protects H9C2 cells against hypoxia-induced apoptosis via the death receptor pathway and mitochondrial pathway.	CASP8
33922439	10.3390/cells10050987	2021	Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP.	CASP8
33974882	10.1016/j.ejphar.2021.174167	2021	Effects of trans-resveratrol on type 1 diabetes-induced up-regulation of apoptosis and mitogen-activated protein kinase signaling in retinal pigment epithelium of Dark Agouti rats.	CASP8
33995372	10.3389/fimmu.2021.656356	2021	Next Generation Sequencing for Detecting Somatic <i>FAS</i> Mutations in Patients With Autoimmune Lymphoproliferative Syndrome.	CASP8
34627429	10.19746/j.cnki.issn.1009-2137.2021.05.018	2021	[Relationships between CASP8, Fas Gene Polymorphisms and the Prognosis of Patients with Non-Hodgkin's Lymphoma in Han Nationality].	CASP8
34945004	10.3390/cancers13246384	2021	Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel.	CASP8
30859901	10.1080/15548627.2019.1591672	2020	Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.	CASP8
30990357	10.1080/15548627.2019.1607694	2020	Cell quality control mechanisms maintain stemness and differentiation potential of P19 embryonic carcinoma cells.	CASP8
31220671	10.1016/j.bioorg.2019.103053	2020	Protective effect of hypoxylonol C and 4,5,4',5'-tetrahydroxy-1,1'-binaphthyl isolated from Annulohypoxylon annulatum against streptozotocin-induced damage in INS-1 cells.	CASP8
31730868	10.1016/j.lfs.2019.117038	2020	Effect of maternal omega-3 fatty acids and vitamin E supplementation on placental apoptotic markers in rat model of early and late onset preeclampsia.	CASP8
31752870	10.1186/s12917-019-2167-3	2020	Effects of prostaglandin F<sub>2α</sub> (PGF<sub>2α</sub>) on cell-death pathways in the bovine corpus luteum (CL).	CASP8
31908105	10.1111/cas.14296	2020	Efficient recruitment of c-FLIP<sub>L</sub> to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma.	CASP8
31974619	10.3892/mmr.2019.10873	2020	Chidamide induces necroptosis via regulation of c‑FLIPL expression in Jurkat and HUT‑78 cells.	CASP8
32075108	10.3390/ijms21041298	2020	C5, A Cassaine Diterpenoid Amine, Induces Apoptosis via the Extrinsic Pathways in Human Lung Cancer Cells and Human Lymphoma Cells.	CASP8
29755111	10.1038/s41417-018-0022-5	2019	Genomic landscape and prognostic analysis of mantle cell lymphoma.	CASP8
29891925	10.1038/s41598-018-27106-9	2019	Cadmium-induced apoptosis in neuronal cells is mediated by Fas/FasL-mediated mitochondrial apoptotic signaling pathway.	CASP8
30061179	10.1042/BSR20180391	2019	<i>In vivo</i> and <i>in vitro</i> effects of hyperplasia suppressor gene on the proliferation and apoptosis of lung adenocarcinoma A549 cells.	CASP8
30175514	10.1111/nep.13487	2019	Loss of receptor interacting protein kinases 3 and caspase-8 augments intrinsic apoptosis in tubular epithelial cell and promote kidney ischaemia-reperfusion injury.	CASP8
31810928	10.21873/anticanres.13878	2019	Evaluation of Combination Treatment Effect With TRAIL-secreting Mesenchymal Stem Cells and Compound C Against Glioblastoma.	CASP8
28199208	10.2741/4549	2018	Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.	CASP8
28427190	10.18632/oncotarget.15843	2018	Pygopus2 inhibits the efficacy of paclitaxel-induced apoptosis and induces multidrug resistance in human glioma cells.	CASP8
28643758	10.4103/0973-1482.176172	2018	Effects of EF-24, RAD001, and paclitaxel on the expression profiles of apoptotic and anti-apoptotic genes.	CASP8
28765878	10.3892/ijmm.2017.3081	2018	Grifola frondosa polysaccharides induce breast cancer cell apoptosis via the mitochondrial-dependent apoptotic pathway.	CASP8
28972304	10.1002/1878-0261.12140	2018	DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.	CASP8
29617412	10.1371/journal.pone.0195116	2018	Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells.	CASP8
29966986	10.1016/j.biopha.2018.06.164	2018	In vitro combinatorial anti-proliferative and immunosuppressive effects of Brucea javanica extract with CX-4945 and imatinib in human T-cell acute lymphoblastic leukemia cells.	CASP8
30111413	10.7534/j.issn.1009-2137.2018.04.025	2018	[Apoptosis of Murine T-Cell Lymphoma EL4 Cells Induced by Murine Cytomegalovirus and Its Mechanism].	CASP8
26905515	10.1007/s00296-016-3443-1	2017	Fas/FasL, Bcl2 and Caspase-8 gene polymorphisms in Chinese patients with rheumatoid arthritis.	CASP8
27176505	10.3892/ijo.2016.3518	2017	The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.	CASP8
27193732	10.2131/jts.41.403	2017	Ochratoxin A mediates MAPK activation, modulates IL-2 and TNF-α mRNA expression and induces apoptosis by mitochondria-dependent and mitochondria-independent pathways in human H9 T cells.	CASP8
27391025	10.1371/journal.pone.0158987	2017	The Interaction of CD154 with the α5β1 Integrin Inhibits Fas-Induced T Cell Death.	CASP8
27678524	10.1016/j.taap.2016.09.021	2017	A microtubule inhibitor, ABT-751, induces autophagy and delays apoptosis in Huh-7 cells.	CASP8
27868169	10.1007/s11010-016-2883-y	2017	Articulatin-D induces apoptosis via activation of caspase-8 in acute T-cell leukemia cell line.	CASP8
27929746	10.1080/15384101.2016.1261226	2017	Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.	CASP8
27998762	10.1016/j.canlet.2016.12.010	2017	Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft model.	CASP8
28154184	10.1074/jbc.M116.754184	2017	Bax/Bak-independent mitochondrial depolarization and reactive oxygen species induction by sorafenib overcome resistance to apoptosis in renal cell carcinoma.	CASP8
28361856		2017	Aberrant promoter hypermethylation of selected apoptotic genes in childhood acute lymphoblastic leukemia among North Indian population.	CASP8
24614587	10.1371/journal.pone.0091359	2016	KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome.	CASP8
25248880	10.3109/10428194.2014.953149	2016	The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.	CASP8
25663566	10.1007/s12016-015-8466-y	2016	Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).	CASP8
25697054	10.1016/j.steroids.2015.02.007	2016	24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8.	CASP8
26142735	10.1007/s13277-015-3720-8	2016	Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein.	CASP8
26398332	10.3892/mmr.2015.4323	2016	Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways.	CASP8
26437781	10.1038/leu.2015.267	2016	A20 targets caspase-8 and FADD to protect HTLV-I-infected cells.	CASP8
26479732	10.1080/09168451.2015.1095065	2016	Advanced glycation end-product (AGE) induces apoptosis in human retinal ARPE-19 cells via promoting mitochondrial dysfunction and activating the Fas-FasL signaling.	CASP8
26549478	10.1016/j.cbi.2015.10.025	2016	Resveratrol induces cell death and inhibits human herpesvirus 8 replication in primary effusion lymphoma cells.	CASP8
24621205	10.3109/00365513.2014.891257	2015	Association of BH3 interacting domain death agonist (BID) gene polymorphisms with proteinuria of immunoglobulin A nephropathy.	CASP8
25060748	10.3892/mmr.2014.2379	2015	Apogossypolone inhibits the proliferation of LNCaP cells in vitro and in vivo.	CASP8
25207815	10.1371/journal.pone.0106788	2015	Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies.	CASP8
25345447	10.1517/17460441.2015.974544	2015	Neuroblastoma models for insights into tumorigenesis and new therapies.	CASP8
25446254	10.1016/j.cellsig.2014.11.014	2015	TRAIL activates JNK and NF-κB through RIP1-dependent and -independent pathways.	CASP8
25470234	10.4161/15548627.2014.981790	2015	Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions.	CASP8
25477070	10.1186/s13045-014-0088-y	2015	c-FLIP is involved in tumor progression of peripheral T-cell lymphoma and targeted by histone deacetylase inhibitors.	CASP8
25534662	10.1007/s00775-014-1221-7	2015	Phosphonomethyl iminodiacetic acid-conjugated cobalt oxide nanoparticles liberate Co(++) ion-induced stress associated activation of TNF-α/p38 MAPK/caspase 8-caspase 3 signaling in human leukemia cells.	CASP8
25551567	10.4161/15548627.2014.984270	2015	Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.	CASP8
25578476	10.1038/leu.2015.9	2015	BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.	CASP8
25738497	10.1371/journal.pone.0117994	2015	Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis.	CASP8
25850729	10.1016/j.leukres.2015.03.010	2015	LFA-1-targeting Leukotoxin (LtxA; Leukothera®) causes lymphoma tumor regression in a humanized mouse model and requires caspase-8 and Fas to kill malignant lymphocytes.	CASP8
26117011	10.7534/j.issn.1009-2137.2015.03.010	2015	[Salinomycin Enhances the Apoptosis of T-cell Acute Lymphoblastic Leukemia Cell Line Jurkat Cells Induced by Vincristine].	CASP8
26195820	10.1128/MCB.00692-15	2015	RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.	CASP8
23582793	10.1016/j.biopha.2013.02.002	2014	c-FLIP does not correlate with response to immunochemotherapy treatment and outcome of patients with nodal diffuse large B-cell lymphoma.	CASP8
23828565	10.1038/cddis.2013.214	2014	Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways.	CASP8
23844036	10.1371/journal.pone.0067577	2014	Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China.	CASP8
24352466	10.1128/JVI.03025-13	2014	Human T-cell leukemia virus type 1 Tax-deregulated autophagy pathway and c-FLIP expression contribute to resistance against death receptor-mediated apoptosis.	CASP8
24370029	10.7534/j.issn.1009-2137.2013.06.017	2014	[Effect of midazolam on mantle cell lymphoma JeKo-1 cell line and its relevant mechanisms].	CASP8
22126780		2013	[Honokiol-induced apoptosis of human non-Hodgkin lymphoma Raji cells and its possible mechanism].	CASP8
22426257	10.1016/j.humimm.2012.02.018	2013	The role of BCL11B in regulating the proliferation of human naive T cells.	CASP8
22860893	10.3109/10428194.2012.717079	2013	Interleukin-24 mediates apoptosis in human B-cells through early activation of cell cycle arrest followed by late induction of the mitochondrial apoptosis pathway.	CASP8
23071110	10.1074/jbc.M112.419747	2013	Protease activity of procaspase-8 is essential for cell survival by inhibiting both apoptotic and nonapoptotic cell death dependent on receptor-interacting protein kinase 1 (RIP1) and RIP3.	CASP8
23193206	10.2337/dc12-0194	2013	Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration.	CASP8
23731686	10.1016/j.jss.2013.04.079	2013	Regulation of tumor necrosis factor-α-induced microvascular endothelial cell hyperpermeability by recombinant B-cell lymphoma-extra large.	CASP8
23770605	10.1038/ng.2652	2013	Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.	CASP8
23804715	10.4049/jimmunol.1202514	2013	Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells.	CASP8
21638304	10.1002/hon.996	2012	Cellular (FLICE) like inhibitory protein (cFLIP) expression in diffuse large B-cell lymphoma identifies a poor prognostic subset, but fails to predict the molecular subtype.	CASP8
21737742	10.1210/me.2011-0046	2012	TSH receptor function is required for normal thyroid differentiation in zebrafish.	CASP8
21952919	10.1002/ijc.26458	2012	Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.	CASP8
21954216	10.1002/pbc.23331	2012	Inhibition of caspase-8 activity caused by overexpression of BCL10 contributes to the pathogenesis of high-grade MALT lymphoma.	CASP8
22010212	10.1158/1078-0432.CCR-11-0513	2012	Important role of caspase-8 for chemosensitivity of ALL cells.	CASP8
22011910	10.1038/jid.2011.316	2012	Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand.	CASP8
22086925	10.1074/jbc.M111.286526	2012	Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression.	CASP8
22173242	10.1038/leu.2011.353	2012	RIP1 is required for IAP inhibitor-mediated sensitization of childhood acute leukemia cells to chemotherapy-induced apoptosis.	CASP8
22190004	10.1038/cddis.2011.131	2012	The role of c-FLIP splice variants in urothelial tumours.	CASP8
22205673	10.2527/jas.2011-4340	2012	9-cis Retinoic acid inhibits cumulus cell apoptosis during the maturation of bovine cumulus-oocyte-complexes.	CASP8
22211869	10.3109/10428194.2011.654117	2012	Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.	CASP8
22221251	10.1111/j.1365-2184.2011.00801.x	2012	A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia.	CASP8
22343728	10.1182/blood-2011-07-367532	2012	Caspase-8 is essential for maintaining chromosomal stability and suppressing B-cell lymphomagenesis.	CASP8
22393362	10.1371/journal.pone.0031366	2012	Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.	CASP8
22551975	10.1038/jid.2012.125	2012	Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling.	CASP8
22884570	10.1016/j.febslet.2012.07.067	2012	Cbl-b-dependent degradation of FLIP(L) is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells.	CASP8
20706274	10.1038/cdd.2010.99	2011	Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression.	CASP8
20812013	10.1007/s00292-010-1372-4	2011	[cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells].	CASP8
20855536	10.1158/1055-9965.EPI-10-0581	2011	Germline variation in apoptosis pathway genes and risk of non-Hodgkin's lymphoma.	CASP8
21198858	10.1111/j.1600-0609.2010.01567.x	2011	Clinical and prognostic significance of apoptotic profile in patients with newly diagnosed nodal diffuse large B-cell lymphoma (DLBCL).	CASP8
21447005	10.1111/j.1600-0609.2011.01617.x	2011	Advances in autoimmune lymphoproliferative syndromes.	CASP8
21531730	10.1074/jbc.M111.224048	2011	A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.	CASP8
21633787	10.1007/s00277-011-1265-5	2011	Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients.	CASP8
21803845	10.1182/blood-2011-04-349670	2011	PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo.	CASP8
19684859	10.1371/journal.pone.0006651	2010	RNA silencing of Mcl-1 enhances ABT-737-mediated apoptosis in melanoma: role for a caspase-8-dependent pathway.	CASP8
19773279	10.1136/oem.2008.044024	2010	Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity.	CASP8
19824885	10.1042/BJ20090455	2010	Fas/CD95 down-regulation in lymphoma cells through acquired alkyllysophospholipid resistance: partial role of associated sphingomyelin deficiency.	CASP8
19890350	10.1038/jid.2009.299	2010	Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.	CASP8
19895884	10.1016/j.cellsig.2009.10.018	2010	Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax are necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.	CASP8
20232432	10.1002/pbc.22463	2010	Low mRNA expression of the apoptosis-related genes CASP3, CASP8, and FAS is associated with low induction treatment response in childhood acute lymphoblastic leukemia (ALL).	CASP8
19239430	10.1111/j.1600-0463.2008.00017.x	2009	Prognostic significance of O6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas.	CASP8
19369931	10.1038/jid.2009.14	2009	Targeting apoptosis defects in cutaneous T-cell lymphoma.	CASP8
19406988	10.1182/blood-2008-10-186536	2009	High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response.	CASP8
19414860	10.1182/blood-2009-01-198697	2009	Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies.	CASP8
19439735	10.1182/blood-2009-02-204230	2009	A single nucleotide polymorphism determines protein isoform production of the human c-FLIP protein.	CASP8
19573080	10.1111/j.1365-2141.2009.07790.x	2009	Common genetic variants in candidate genes and risk of familial lymphoid malignancies.	CASP8
19826422	10.1038/sj.bjc.6605352	2009	Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.	CASP8
19838173	10.1038/ncb1980	2009	FLIP-mediated autophagy regulation in cell death control.	CASP8
19906199	10.1111/j.1365-3083.2009.02330.x	2009	The effect of microenvironmental CD40 signals on TRAIL- and drug-induced apoptosis in follicular lymphoma cells.	CASP8
19906200	10.1111/j.1365-3083.2009.02331.x	2009	Feedback regulation of mitochondria by caspase-9 in the B cell receptor-mediated apoptosis.	CASP8
17659339	10.1016/j.leukres.2007.05.024	2008	Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.	CASP8
17932249	10.1182/blood-2007-04-085399	2008	ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.	CASP8
17988665	10.1016/j.yexcr.2007.10.001	2008	Interferon-alpha induces transient upregulation of c-FLIP through NF-kappaB activation.	CASP8
18042067	10.1111/j.1365-2559.2007.02882.x	2008	Expression of c-FLIP is primarily detected in diffuse large B-cell lymphoma and Hodgkin's lymphoma and correlates with lack of caspase 8 activation.	CASP8
18314443	10.1182/blood-2007-08-109074	2008	Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.	CASP8
18354056	10.1124/jpet.107.136077	2008	Dependence of reactive oxygen species and FLICE inhibitory protein on lipofectamine-induced apoptosis in human lung epithelial cells.	CASP8
18381704	10.1002/hon.852	2008	Caspase polymorphisms and genetic susceptibility to multiple myeloma.	CASP8
18474261	10.1016/j.niox.2008.04.019	2008	Role of S-nitrosylation in apoptosis resistance and carcinogenesis.	CASP8
18556415	10.3324/haematol.12127	2008	The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP.	CASP8
18606651	10.4049/jimmunol.181.2.1001	2008	CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL.	CASP8
18625728	10.1128/MCB.00418-08	2008	The protein kinase C-responsive inhibitory domain of CARD11 functions in NF-kappaB activation to regulate the association of multiple signaling cofactors that differentially depend on Bcl10 and MALT1 for association.	CASP8
18691973	10.1016/j.molcel.2008.06.008	2008	The paracaspase MALT1 controls caspase-8 activation during lymphocyte proliferation.	CASP8
16740746	10.1158/1078-0432.CCR-06-0076	2007	FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.	CASP8
16901543	10.1016/j.molimm.2006.06.005	2007	The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP.	CASP8
17071630	10.1093/carcin/bgl196	2007	Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.	CASP8
17210689	10.1158/0008-5472.CAN-06-1415	2007	Dominant-negative Fas mutation is reversed by down-expression of c-FLIP.	CASP8
17237443	10.4049/jimmunol.178.3.1923	2007	Selective inhibition of IkappaB kinase sensitizes mantle cell lymphoma B cells to TRAIL by decreasing cellular FLIP level.	CASP8
17275920	10.1016/j.imlet.2006.12.009	2007	Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.	CASP8
17277134	10.4049/jimmunol.178.4.2287	2007	Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to fas-induced apoptosis.	CASP8
17301064	10.1093/carcin/bgm028	2007	Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade.	CASP8
17308066	10.1158/1535-7163.MCT-06-0544	2007	Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.	CASP8
17376892	10.1182/blood-2006-08-038398	2007	Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL.	CASP8
17378240		2007	CD40L and IL-4 stimulation of acute lymphoblastic leukemia cells results in upregulation of mRNA level of FLICE--an important component of apoptosis.	CASP8
17454639	10.1080/10428190601186002	2007	Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation.	CASP8
17456054	10.1111/j.1365-2141.2007.06576.x	2007	Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.	CASP8
17462996	10.1074/jbc.M610610200	2007	Caspase-8 and c-FLIPL associate in lipid rafts with NF-kappaB adaptors during T cell activation.	CASP8
17487744	10.1080/10428190701242358	2007	Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.	CASP8
17495957	10.1038/sj.jid.5700868	2007	Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells.	CASP8
17532763	10.1111/j.1600-0609.2007.00865.x	2007	Absence of CASP7 and CASP8 mutation in gastrointestinal lymphomas.	CASP8
17558734	10.1080/02656730701299682	2007	Enhancement of macrosphelide-induced apoptosis by mild hyperthermia.	CASP8
17585225	10.1097/01.anes.0000268389.39436.66	2007	Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling.	CASP8
17585337	10.1038/sj.cdd.4402187	2007	p38 MAPK and MSK1 mediate caspase-8 activation in manganese-induced mitochondria-dependent cell death.	CASP8
17626072	10.1128/JVI.02241-06	2007	Bortezomib induces apoptosis of Epstein-Barr virus (EBV)-transformed B cells and prolongs survival of mice inoculated with EBV-transformed B cells.	CASP8
17659053	10.1111/j.1365-2141.2007.06697.x	2007	In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.	CASP8
17899551	10.1002/eji.200737181	2007	Synergistic activation of interferon-beta gene transcription by the viral FLICE inhibitory protein of Kaposi's sarcoma-associated herpesvirus and type I IFN activators.	CASP8
15572586	10.1182/blood-2004-08-3052	2006	Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA.	CASP8
15876872	10.4161/cc.4.4.1595	2006	Inhibition of caspase 9 and not caspase 8 mediated apoptosis may determine clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.	CASP8
16304056	10.1182/blood-2005-06-2601	2006	c-FLIP confers resistance to FAS-mediated apoptosis in anaplastic large-cell lymphoma.	CASP8
16357130	10.1158/0008-5472.CAN-05-2801	2006	TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies.	CASP8
16403915	10.1182/blood-2005-06-2567	2006	HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP).	CASP8
16441226	10.1517/14728222.10.1.27	2006	The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.	CASP8
16445828	10.1111/j.1365-2141.2005.05898.x	2006	cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy.	CASP8
16498450	10.1038/nri1787	2006	cFLIP regulation of lymphocyte activation and development.	CASP8
16545138	10.1186/1471-2407-6-75	2006	CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways.	CASP8
16579975	10.1016/j.bcp.2006.02.015	2006	Cellular FLICE-like inhibitory protein (c-FLIP): a novel target for Taxol-induced apoptosis.	CASP8
16699949	10.1007/s10495-006-8048-9	2006	The TRAIL apoptotic pathway mediates proteasome inhibitor induced apoptosis in primary chronic lymphocytic leukemia cells.	CASP8
16751281	10.1073/pnas.0507809103	2006	The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas.	CASP8
16761935	10.1586/14737140.6.6.911	2006	Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.	CASP8
16848771	10.1111/j.1365-2141.2006.06186.x	2006	Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay.	CASP8
16920630	10.1016/j.cub.2006.06.062	2006	Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation.	CASP8
15493834		2005	[Antitumor mechanism of 3-bromopropionylamino benzoylurea on leukemia and lymphoma].	CASP8
15498850	10.1182/blood-2004-04-1360	2005	15-Deoxy-delta 12,14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins.	CASP8
15576477	10.1182/blood-2004-07-2716	2005	Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomas.	CASP8
15696611	10.1007/s00262-004-0538-4	2005	CD4+ T cells kill Id+ B-lymphoma cells: FasLigand-Fas interaction is dominant in vitro but is redundant in vivo.	CASP8
15717329	10.1002/pmic.200401046	2005	Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics.	CASP8
15748896	10.1016/j.yexcr.2004.11.015	2005	Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells.	CASP8
15755279	10.1111/j.1365-2141.2005.05378.x	2005	c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome.	CASP8
15772077	10.1074/jbc.M414358200	2005	Caspase-10 triggers Bid cleavage and caspase cascade activation in FasL-induced apoptosis.	CASP8
15802594	10.1126/science.1110902	2005	Cell biology. Kinasing and clipping down the NF-kappa B trail.	CASP8
15851579	10.1167/iovs.04-1039	2005	Human RPE expression of cell survival factors.	CASP8
15878978	10.1182/blood-2005-01-0427	2005	The fully human anti-CD30 antibody 5F11 activates NF-{kappa}B and sensitizes lymphoma cells to bortezomib-induced apoptosis.	CASP8
15924153	10.1038/labinvest.3700291	2005	Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.	CASP8
16010441		2005	Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.	CASP8
16019850	10.1080/02656730400025404	2005	A hydrogen peroxide-generating agent, 6-formylpterin, enhances heat-induced apoptosis.	CASP8
16099454	10.1016/j.yexcr.2005.06.021	2005	Requirement of c-Jun NH2-terminal kinase activation in interferon-alpha-induced apoptosis through upregulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in Daudi B lymphoma cells.	CASP8
16140959	10.1158/0008-5472.CAN-04-4278	2005	Tumor necrosis factor-related apoptosis-inducing ligand-mediated proliferation of tumor cells with receptor-proximal apoptosis defects.	CASP8
16173963	10.1111/j.1365-2141.2005.05720.x	2005	Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells.	CASP8
12934075	10.1038/sj.cdd.4401271	2004	Caspase-9 is activated in a cytochrome c-independent manner early during TNFalpha-induced apoptosis in murine cells.	CASP8
12957657	10.1016/s0891-5849(03)00391-5	2004	Fas-stimulated generation of reactive oxygen species or exogenous oxidative stress sensitize cells to Fas-mediated apoptosis.	CASP8
12963734	10.1074/jbc.M304793200	2004	Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro.	CASP8
14563855	10.1074/jbc.M304199200	2004	The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.	CASP8
14654978		2004	TGF-beta1 inhibits Fas-mediated apoptosis by regulating surface Fas and cFLIPL expression in human leukaemia/lymphoma cells.	CASP8
14871997	10.1158/1078-0432.ccr-0362-3	2004	Multiple myeloma regression mediated by bruceantin.	CASP8
14959858	10.1080/1042819031000116652	2004	Farnesyl transferase inhibitors enhance death receptor signals and induce apoptosis in multiple myeloma cells.	CASP8
14962357	10.1179/135100003225002835	2004	The role of oxidant injury in the pathophysiology of human thalassemias.	CASP8
14977850	10.1158/1078-0432.ccr-1365-02	2004	Tumor necrosis factor-related apoptosis-inducing ligand cooperates with anticancer drugs to overcome chemoresistance in antiapoptotic Bcl-2 family members expressing jurkat cells.	CASP8
15003890		2004	Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.	CASP8
15009062	10.1111/j.1365-2141.2004.04849.x	2004	Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells.	CASP8
15033760	10.1196/annals.1299.073	2004	Peptides from anchovy sauce induce apoptosis in a human lymphoma cell (U937) through the increase of caspase-3 and -8 activities.	CASP8
15078899	10.1084/jem.20031080	2004	c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.	CASP8
15096587	10.1073/pnas.0400765101	2004	Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death.	CASP8
15101724	10.1080/10428190310001595713	2004	Differences in the expression of apoptotic proteins in Burkitt's lymphoma cell lines: potential models for screening apoptosis-inducing agents.	CASP8
15197489	10.1007/s00280-004-0831-0	2004	Involvement of oxidative stress and caspase activation in paclitaxel-induced apoptosis of primary effusion lymphoma cells.	CASP8
15273737	10.1038/sj.onc.1207848	2004	Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.	CASP8
15354734	10.1097/00129039-200406000-00002	2004	Expression of c-FLIP in classic and nodular lymphocyte-predominant Hodgkin lymphoma.	CASP8
15359646	10.1080/10428190410001663617	2004	In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.	CASP8
15370202	10.1080/10428190410001683642	2004	PI3-kinase regulates survival of chronic lymphocytic leukemia B-cells by preventing caspase 8 activation.	CASP8
12216112	10.1038/emm.2002.29	2003	Differential effects of Fas cross-linking on phospholipase D activation and related lipid metabolism in Fas-resistant A20 cells.	CASP8
12415011	10.1242/jcs.00153	2003	Caspase-dependent initiation of apoptosis and necrosis by the Fas receptor in lymphoid cells: onset of necrosis is associated with delayed ceramide increase.	CASP8
12482880	10.1074/jbc.M204178200	2003	The mycotoxin penicillic acid inhibits Fas ligand-induced apoptosis by blocking self-processing of caspase-8 in death-inducing signaling complex.	CASP8
12506034	10.1182/blood-2002-06-1770	2003	TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.	CASP8
12507887	10.1016/S0002-9440(10)63795-9	2003	Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.	CASP8
12553006		2003	TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8.	CASP8
12556444	10.1074/jbc.M212392200	2003	Inhibition of glucose metabolism sensitizes tumor cells to death receptor-triggered apoptosis through enhancement of death-inducing signaling complex formation and apical procaspase-8 processing.	CASP8
12576463		2003	Phytosphingosine induces apoptotic cell death via caspase 8 activation and Bax translocation in human cancer cells.	CASP8
12667669	10.1016/s0022-1759(02)00554-9	2003	A method for functional evaluation of caspase activation pathways in intact lymphoid cells using electroporation-mediated protein delivery and flow cytometric analysis.	CASP8
12684647		2003	Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.	CASP8
12688354	10.1080/1042819021000029984	2003	Flavopiridol induces apoptosis in B-cell chronic lymphocytic leukaemia cells through a p38 and ERK MAP kinase-dependent mechanism.	CASP8
12700660	10.1038/sj.onc.1206280	2003	Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.	CASP8
12776188	10.1038/sj.onc.1206407	2003	Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.	CASP8
12804643	10.1016/s0145-2126(03)00018-3	2003	Differential recruitment of caspase 8 to cFlip confers sensitivity or resistance to Fas-mediated apoptosis in a subset of familial lymphoma patients.	CASP8
12897143	10.1128/MCB.23.16.5716-5725.2003	2003	Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells.	CASP8
12944404	10.1074/jbc.M303868200	2003	Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered by anti-Gb3/CD77 mAb and verotoxin-1.	CASP8
12975549	10.1159/000072407	2003	The molecular mechanism of arsenic trioxide-induced apoptosis and oncosis in leukemia/lymphoma cell lines.	CASP8
14559832		2003	Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.	CASP8
14617009	10.1046/j.1365-2141.2003.04644.x	2003	Frequent aberrant promoter hypermethylation of O6-methylguanine-DNA methyltransferase and death-associated protein kinase genes in immunodeficiency-related lymphomas.	CASP8
11598198	10.1091/mbc.12.10.3139	2002	p38-mediated regulation of an Fas-associated death domain protein-independent pathway leading to caspase-8 activation during TGFbeta-induced apoptosis in human Burkitt lymphoma B cells BL41.	CASP8
11726649	10.1074/jbc.M105902200	2002	Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma.	CASP8
11779164	10.1006/bbrc.2001.6199	2002	Actin cytoskeleton is required for early apoptosis signaling induced by anti-Fas antibody but not Fas ligand in murine B lymphoma A20 cells.	CASP8
11801463		2002	Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.	CASP8
11830587	10.1074/jbc.M110480200	2002	The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex.	CASP8
11895917		2002	Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.	CASP8
11943736	10.1016/S0002-9440(10)62578-3	2002	Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.	CASP8
12072193	10.1016/s0198-8859(02)00405-6	2002	CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells.	CASP8
12154021		2002	Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.	CASP8
10970901	10.1074/jbc.M007369200	2001	Apoptosis induced by cadmium in human lymphoma U937 cells through Ca2+-calpain and caspase-mitochondria- dependent pathways.	CASP8
11090192	10.1128/jvi.74.24.11919-11927.2000	2001	Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicity.	CASP8
11106658	10.1074/jbc.M008431200	2001	c-Jun NH2-terminal kinase activation leads to a FADD-dependent but Fas ligand-independent cell death in Jurkat T cells.	CASP8
11122106	10.1046/j.1365-2141.2000.02404.x	2001	Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.	CASP8
11187905	10.1038/sj.leu.2401954	2001	Resistance to CD95-mediated apoptosis through constitutive c-FLIP expression in a non-Hodgkin's lymphoma B cell line.	CASP8
11222383	10.1182/blood.v97.5.1378	2001	Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.	CASP8
11222719	10.1128/JVI.75.6.2938-2945.2001	2001	Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein.	CASP8
11298116	10.1046/j.1365-2230.2001.00796.x	2001	Gene expression profile in a case of primary cutaneous CD30-negative large T-cell lymphoma with a blastic phenotype.	CASP8
11306492		2001	Inhibition of caspases maintains the antineoplastic function of gammadelta T cells repeatedly challenged with lymphoma cells.	CASP8
11360204	10.1038/sj.onc.1204318	2001	Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL.	CASP8
11376869	10.1016/s0301-472x(01)00627-0	2001	Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.	CASP8
11378538	10.3109/10428190109057980	2001	Caspases: conductors of the cell death machinery in lymphoma cells.	CASP8
11423254	10.1016/s0959-8049(01)00115-0	2001	KSHV/HHV8-associated lymphoproliferations in the AIDS setting.	CASP8
11439165	10.1046/j.1365-3083.2001.00941.x	2001	Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different flip isoforms.	CASP8
11441077	10.4049/jimmunol.167.2.733	2001	B cell receptor cross-linking triggers a caspase-8-dependent apoptotic pathway that is independent of the death effector domain of Fas-associated death domain protein.	CASP8
11454987	10.1038/labinvest.3780310	2001	Loss of Fas (CD95/APO-1) regulatory function is an important step in early MALT-type lymphoma development.	CASP8
11472346	10.1046/j.1365-2141.2001.02902.x	2001	Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis.	CASP8
11489989	10.4049/jimmunol.167.4.2068	2001	A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells.	CASP8
11598799	10.1038/sj.cdd.4400914	2001	Inhibition of histone deacetylase activity enhances Fas receptor-mediated apoptosis in leukemic lymphoblasts.	CASP8
11604558	10.1097/00001813-200109000-00009	2001	Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell line.	CASP8
11673559	10.4049/jimmunol.167.9.5404	2001	Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway.	CASP8
10652256	10.1242/jcs.113.4.635	2000	4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death.	CASP8
10713706	10.1038/sj.onc.1203401	2000	Differential role of caspase-8 and BID activation during radiation- and CD95-induced apoptosis.	CASP8
10894161	10.1016/s1074-7613(00)80212-5	2000	Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5.	CASP8
10946276	10.4049/jimmunol.165.5.2500	2000	Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.	CASP8
11004695	10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH685&gt;3.0.CO;2-M	2000	Frequent nuclear localization of ICAD and cytoplasmic co-expression of caspase-8 and caspase-3 in human lymphomas.	CASP8
11059770		2000	Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.	CASP8
11067917	10.4049/jimmunol.165.10.5612	2000	TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria.	CASP8
10187771	10.1074/jbc.274.15.9962	1999	Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-kappaB transcription factor and c-Jun N-terminal kinase.	CASP8
10208923	10.1006/viro.1999.9672	1999	Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line.	CASP8
10232592		1999	Mistletoe lectin activates caspase-8/FLICE independently of death receptor signaling and enhances anticancer drug-induced apoptosis.	CASP8
10452984		1999	B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway.	CASP8
10468853	10.1046/j.1365-2141.1999.01586.x	1999	FADD expression and caspase activation in B-cell lymphomas resistant to Fas-mediated apoptosis.	CASP8
10477698		1999	Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma.	CASP8
10490833	10.1038/sj.onc.1202878	1999	The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation.	CASP8
10500797		1999	Apoptosis. Molecules and mechanisms.	CASP8
10510092	10.1084/jem.190.7.1025	1999	The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.	CASP8
10548502	10.1006/bbrc.1999.1641	1999	TRAIL causes cleavage of bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells.	CASP8
10549602	10.1080/095530099139412	1999	Ionizing radiation and the activation of caspase-8 in highly apoptosis-sensitive lymphoma cells.	CASP8
10598877	10.1111/j.1699-0463.1999.tb01508.x	1999	Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas.	CASP8
9880544	10.1074/jbc.274.3.1646	1999	Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex.	CASP8
9596680		1998	Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells.	CASP8
9774341	10.1093/emboj/17.20.5974	1998	DEDD, a novel death effector domain-containing protein, targeted to the nucleolus.	CASP8
9395239	10.1038/sj.onc.1201399	1997	p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.	CASP8
170210	10.1002/ijc.2910160114	1975	Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA.	CASP8
